Researchers are just beginning to discover the gene mutations that influence drug response.
The project could also reveal mutations that influence a patient's prognosis.
This study demonstrated that random mutagenesis and bioselection procedures could be used to identify mutations that influence important properties of bacterial Rubisco; these residues would not have been identified by other methods.
The aim was to investigate candidate genes in these regions and to identify putative causative mutations that influence these traits.
Several mutations that influence the autoactivation of human trypsinogen have been published and are discussed in the context of the development of pancreatitis [ 4, 5].
The identified mutations can be biologically interpreted as a set of mutations that influence the pathway level gene expression, and thus the mutations can be considered functional in cancer, which can be further prioritized as cancer drivers.
Our results show that breaking the interactions that restrain the fusion peptide is rate-limiting both for virion arrest and for hemifusion at the pH of endosomes from which influenza virus penetrates (approximately 5 to 5.5); this interpretation is consistent with the dominance hierarchy of mutations that influence the threshold pH for fusion (Steinhauer et al., 1996).
Nowadays, the experimental way of random mutagenesis and bioselection could be used to identify mutations that influence important properties of Rubisco [ 13, 28- 30], but the vast amount of candidates and the repetitive lab work make the process slow, unpredictable and tedious.
A multidisciplinary team combined clinical phenotyping, exome sequencing, bioinformatics, and functional studies, eventually finding the causative mutation that influenced the future treatment of the child.
Further, there is a need to better understand a) the potential for fiber-induced mutations that influence cancer, b) relevant mechanisms of translocation of different fiber types to extrapulmonary sites, c) health effects outside of the respiratory tract and pleural tissue, and d) the role of population variability and sensitivity to asbestos-induced adverse health end points.
